A7303012
Swertiamarine , Analysis of standard products, ≥98% , 17388-39-5
Synonym(s):
(4aR,5R,6S)-5-Ethenyl-6-(β-D -glucopyranosyloxy)-4,4a,5,6-tetrahydro-4a-hydroxy1H,3H-pyrano[3,4-c]pyran-1-one;4,4a,5,6-Tetrahydro-4aα-hydroxy-1-oxo-5β-vinyl-1H,3H-pyrano[3,4-c]pyran-6-yl β-D -glucopyranoside;Swertiamarin;Swertiamarine;Swertiamaroside
| Pack Size | Price | Stock | Quantity |
| 20MG | RMB72.00 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 113-114° |
| alpha | D20 -127° (c = 1 in 96% ethanol) |
| Boiling point: | 649.3±55.0 °C(Predicted) |
| Density | 1.57±0.1 g/cm3(Predicted) |
| storage temp. | Sealed in dry,Store in freezer, under -20°C |
| solubility | DMSO : 250 mg/mL (667.84 mM; Need ultrasonic) |
| form | Solid |
| pka | 11.56±0.60(Predicted) |
| color | White to Yellow to Orange |
| λmax | 238nm(MeOH)(lit.) |
| Merck | 14,9010 |
| BRN | 55278 |
| Stability: | Hygroscopic |
| InChIKey | HEYZWPRKKUGDCR-QBXMEVCASA-N |
| CAS DataBase Reference | 17388-39-5(CAS DataBase Reference) |
Description and Uses
Swertimarine is an extract from Enicostemma littorale which is an herb used in the treatment of type 1 and 2 diabetes. Used to sensitize the cells to hypolipidemic conditions and insulin.
Safety
| Symbol(GHS) |     GHS05,GHS06,GHS08,GHS09 |
| Signal word | Danger |
| Hazard statements | H301-H314-H317-H351-H410 |
| Precautionary statements | P501-P273-P272-P260-P270-P202-P201-P264-P280-P391-P308+P313-P362+P364-P303+P361+P353-P333+P313-P301+P330+P331-P301+P310+P330-P304+P340+P310-P305+P351+P338+P310-P405 |
| Safety Statements | 24/25 |
| WGK Germany | 3 |
| RTECS | UQ1366700 |
| HS Code | 29389090 |
| Toxicity | mouse,LD50,intraperitoneal,> 8gm/kg (8000mg/kg),BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY),Zhongcaoyao. Chinese Traditional and Herbal Medicine. Vol. 13, Pg. 464, 1982. |
